STAA Sep 2024 42.500 call
- Business Wire
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
LAKE FOREST, Calif., June 05, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Williams, Chief Financial Officer, at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference, which will be held in Miami, Florida.
- Simply Wall St.
Is It Time To Consider Buying STAAR Surgical Company (NASDAQ:STAA)?
STAAR Surgical Company ( NASDAQ:STAA ), is not the largest company out there, but it received a lot of attention from a...
- Zacks
Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
Review Staar Surgical's (STAA) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
